Charles Halouze

Title: Charles Halouze: Innovator in Recombinant Vector Technology

Introduction

Charles Halouze is a notable inventor based in Rennes, France. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant vectors for the production and secretion of peptides and proteins. His innovative work has implications in both pharmaceutical applications and large-scale production processes.

Latest Patents

Halouze holds a patent for a recombinant vector designed for producing and secreting peptides or proteins of interest by propionibacteria. The patent details a recombinant vector that expresses and secretes at least one eukaryotic peptide or protein of interest. This vector includes a nucleic acid sequence encoding a propionibacterial signal peptide, which is translationally fused to the sequence encoding the eukaryotic peptide or protein. The invention has potential applications in the pharmaceutical field and for the large-scale production of valuable peptides and proteins.

Career Highlights

Throughout his career, Halouze has worked with prestigious institutions such as the National Institute of Health and Medical Research and the National Institute for Agricultural Research. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Halouze has collaborated with notable colleagues, including Gwenael Jan and Marie-Thérèse Dimanche-Boitrel. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Charles Halouze's contributions to recombinant vector technology exemplify the impact of innovative thinking in biotechnology. His work continues to influence the production of important peptides and proteins, showcasing the importance of research and collaboration in advancing scientific knowledge.